Drug Patent Expirations in October 2011

Drug Patent Expirations in October 2011

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
ZOLINZA Merck vorinostat 6,087,367 Oct 4, 2011
ZORBTIVE Emd Serono somatropin recombinant 5,288,703 Oct 7, 2011
NUTRESTORE Emmaus Medcl glutamine 5,288,703 Oct 7, 2011
ATACAND Astrazeneca candesartan cilexetil 7,538,133*PED Oct 18, 2011
ATACAND HCT Astrazeneca candesartan cilexetil; hydrochlorothiazide 7,538,133*PED Oct 18, 2011
ATACAND Astrazeneca candesartan cilexetil 5,705,517*PED Oct 18, 2011
ATACAND HCT Astrazeneca candesartan cilexetil; hydrochlorothiazide 5,705,517*PED Oct 18, 2011
ELIGARD Tolmar Therap leuprolide acetate 5,324,519 Oct 20, 2011
SYMBYAX Lilly fluoxetine hydrochloride; olanzapine 5,229,382*PED Oct 23, 2011
ZYPREXA RELPREVV Eli Lilly Co olanzapine pamoate 5,229,382*PED Oct 23, 2011
ZYPREXA Lilly olanzapine 5,627,178*PED Oct 23, 2011
ZYPREXA Lilly olanzapine 5,817,656*PED Oct 23, 2011
ZYPREXA Lilly olanzapine 5,817,657*PED Oct 23, 2011
ZYPREXA Lilly olanzapine 5,817,655*PED Oct 23, 2011
ZYPREXA Lilly olanzapine 5,229,382*PED Oct 23, 2011
ZYPREXA ZYDIS Lilly olanzapine 5,229,382*PED Oct 23, 2011

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

Courtesy of DrugPatentWatch.com


Leave a Reply